Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Sandercock Colin Create: Alert

All | News | Filings
Date FiledTypeDescription
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/29/2022 4 Sandercock Colin (SVP, GENERAL COUNSEL) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 60,000 options to buy @ $6.91, valued at $414.6k
Granted 16,667 options to buy @ $5.01, valued at $83.5k
02/12/2021 4 Sandercock Colin (SVP, General Counsel and Sec) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 50,000 options to buy @ $15.55, valued at $777.5k
08/10/2020 4/A Sandercock Colin (SVP, General Counsel and Sec) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Sold 13,374 shares @ $20, valued at $267.5k
Exercised 13,374 options to buy @ $7.5, valued at $100.3k
08/07/2020 4 Sandercock Colin (SVP, General Counsel and Sec) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Sold 13,274 shares @ $20, valued at $265.5k
Exercised 13,274 options to buy @ $7.5, valued at $99.6k
08/05/2020 4 Sandercock Colin (SVP, General Counsel and Sec) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Sold 6,425 shares @ $20, valued at $128.5k
Sold 201 shares @ $20.05, valued at $4k
Exercised 6,425 options to buy @ $7.5, valued at $48.2k
Exercised 201 options to buy @ $7.5, valued at $1.5k
02/24/2020 4/A Sandercock Colin (SVP, General Counsel and Sec) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Bought 100 shares @ $7.35, valued at $735
Bought 15,025 shares @ $7.9, valued at $118.7k
02/12/2020 4 Sandercock Colin (SVP, General Counsel and Sec) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 20,000 options to buy @ $16.26, valued at $325.2k
06/10/2019 4 Sandercock Colin (SVP, General Counsel and Sec) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Bought 2,000 shares @ $7.1, valued at $14.2k
Bought 14,938 shares @ $7.93, valued at $118.5k
03/08/2019 4 Sandercock Colin (SVP, General Counsel and Sec) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 50,000 options to buy @ $6.42, valued at $321k
Granted 100,000 options to buy @ $7.5, valued at $750k
12/27/2017 4 Sandercock Colin (SVP, General Counsel and Sec) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 150,000 options @ $7.5, valued at $1.1M
12/27/2017 3 Sandercock Colin (SVP, General Counsel and Sec) has filed a Form 3 on Cue Biopharma, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy